Chinese Vitamin C Makers Fabricated Export Docs, Jury Told

Law360, New York (March 4, 2013, 5:31 PM EST) -- China Pharmaceutical Group Ltd.'s executive director agreed Monday that vitamin C manufacturers fabricated customs documents to get around a government-mandated price floor, starting the second week of a trial over an alleged price-fixing conspiracy among Chinese vitamin C makers.

Answering questions from an attorney representing U.S. vitamin C purchasers, CPG's Feng Zhenying said vitamin C makers could submit false documents to Chinese customs officials when companies wanted to sell the product below the mandated $3.35 price floor. U.S. customers sometimes demanded vitamin C prices that were...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.